Featured Research

from universities, journals, and other organizations

Pregnant Women Consuming Flaxseed Oil Have High Risk Of Premature Birth

Date:
October 29, 2008
Source:
University of Montreal
Summary:
The risks of a premature birth quadruple if flaxseed oil is consumed in the last two trimesters of pregnancy, according to a new study.

A study has found that the risks of a premature birth quadruple if flaxseed oil is consumed in the last two trimesters of pregnancy. The research was conducted by Professor Anick Bérard of the Université de Montréal's Faculty of Pharmacy and the Sainte-Justine Hospital Research Center and Master's student Krystel Moussally.

In Canada, 50 percent of pregnant women take prescription medication. Yet many of them prefer to use natural health products during the pregnancy. "We believe these products to be safe because they are natural. But in reality, they are chemical products and we don't know many of the risks and benefits of these products contrarily to medication," says Bérard.

Bérard and Moussally set out to conduct one of the largest studies ever undertaken on by analyzing data from 3354 Quebec women. The first part of the research established that close to 10 percent of women between 1998 and 2003 used natural health products during their pregnancy. Before and after pregnancy they were respectively 15 and 14 percent to use these products. The increase means that about a third of women consuming natural health products stopped during the pregnancy.

The most consumed natural health products by pregnant women are chamomile (19 percent), green tea (17 percent), peppered mint (12 percent), and flaxseed oil (12 percent). Bérard and Moussally correlated these products to premature births and only one product had a very strong correlation: flaxseed oil.

"In the general population, the average rate of premature births is 2 to 3 percent. But for women consuming flaxseed oil in their last two trimesters that number jumps up to 12 percent," says Bérard. "It's an enormous risk."

The correlation existed only with flaxseed oil, yet women consuming the actual seed were unaffected. Even if more studies must be undertaken to verify these results, Bérard recommends caution when it comes to consuming flaxseed oil.


Story Source:

The above story is based on materials provided by University of Montreal. Note: Materials may be edited for content and length.


Cite This Page:

University of Montreal. "Pregnant Women Consuming Flaxseed Oil Have High Risk Of Premature Birth." ScienceDaily. ScienceDaily, 29 October 2008. <www.sciencedaily.com/releases/2008/10/081027140817.htm>.
University of Montreal. (2008, October 29). Pregnant Women Consuming Flaxseed Oil Have High Risk Of Premature Birth. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2008/10/081027140817.htm
University of Montreal. "Pregnant Women Consuming Flaxseed Oil Have High Risk Of Premature Birth." ScienceDaily. www.sciencedaily.com/releases/2008/10/081027140817.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) — The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) — The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) — The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) — In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins